تهيئة المرضى والإعداد الجيّد من الوسائل المهمّة التي ينبغي إتباعها خلال الزيارة التحضيرية لقسطرة القلب أو أثناء التنويم، لذلك قمت بإعداد ملف توعوي (مستعيناً بالمصادر العالمية) أستخدمه في عيادتي على شكل ملصق (QR Code) يحوي تعليمات مكتوبة و مقطع مرئي قصير يوضح قسطرة شرايين القلب.
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
DOACs after #TAVR to prevent HALT? NOTION-4: ⬇️ HALT during 3 mo of DOAC, but NO significant difference at 12 mo + ⬆️ death, stroke, or major bleeding. No support for routine use without OAC indication. @DrArifK @YWillemen @Jani_MD_
More in #JACC: bit.ly/45TsrqR
🫀 LV thrombus: DOACs vs VKAs
Meta-analysis:
35 studies | 6,437 patients
🔹 LVT resolution: OR 1.17 (0.99–1.39) — NS
🧠 Ischemic stroke: OR 0.77 (0.65–0.92)
🩸 Major bleeding: OR 0.62 (0.48–0.79)
⚠️ RCT-only evidence remains inconclusive.. Need more RCTs
academic.oup.com/ehjopen/art…
#CardioTwitter #EHJOpen #LVThrombus #DOACs #Anticoagulation #ESC
#CardioTwitter #Anticoagulation
COURAGE Trial – 25-Year Follow-up | JAMA 2026
A new extended follow-up of the landmark COURAGE trial, published in JAMA on November 7, 2026, revisits a fundamental question in interventional cardiology:
Question:
Does routine upfront PCI improve long-term prognosis in patients with stable coronary artery disease?
Key findings:
-959 patients included in the extended follow-up.
-Median follow-up: 15 years; maximum: 25 years.
-Compared upfront PCI + optimal medical therapy (OMT) versus OMT alone.
-No significant reduction in death or MI with upfront PCI.
HR 1.01 (95% CI 0.88–1.15; P=0.89). JAMA Network +1
Clinical takeaway:
The findings reinforce that PCI in stable CAD should primarily be driven by:
-Persistent angina despite guideline-directed medical therapy.
-Significant ischemia and appropriate coronary anatomy.
-High-risk anatomy or other clinical indications.
Bottom line:
PCI remains an important tool for symptom relief and selected clinical indications, but routine upfront PCI should not be assumed to improve survival or prevent MI in stable CAD.
The findings should be interpreted in light of the post-hoc observational follow-up, predominantly male veteran population, and older PCI era.
#InterventionalCardiology #COURAGE #PCI #CAD
Original publication:
jamanetwork.com/journals/jam…
3
354
🆕2026 SCAI SHOCK Classification Expert Consensus Update
The new expert consensus update provides refined stage definitions, a greater focus on objective assessment, expanded guidance across cardiogenic shock phenotypes, and practical approaches to serial reassessment and clinical implementation.
Recognize severity. Reassess trajectory. Communicate across specialties.
Learn more ➡️ scai.org/media-center/news-a…
#SCAISHOCK #CardiogenicShock #InterventionalCardiology @SrihariNaiduMD @MyJSCAI @agtruesdell
نواصل تطوير خدمات علاج إرتفاع ضغط الدم المقاوم للأدوية في مركز إبراهيم الجفالي لأمراض القلب بمستشفى النور التخصصي بمكة المكرمة، بإجراء ثاني حالة لكيّ أعصاب الشرايين الكلوية (Renal Denervation)، بالتعاون مع شركة Recor Medical، بإستخدام تقنية الموجات فوق الصوتية (Ultrasound Renal Denervation).
خطوة جديدة نحو توطين التقنيات العلاجية المتقدمة والارتقاء برعاية مرضى القلب وإرتفاع ضغط الدم بمكة المكرمة.
شكراً للفريق الطبي تمريض، تخدير، و فنيين أشعة لتعاونهم و جهودهم المميزة في إنجاح العمل.
#RenalDenervation #Hypertension #Cardiology
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
#بكم_نتميز | ✨
بكفاءاتنا نفخر
خبرات نوعية وكفاءات وطنية تصنع الفرق وترتقي بجودة الرعاية الصحية
في #تجمع_مكة_المكرمة_الصحي
#لتبقى_مكة_بصحة
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
IABP vs Impella for LV Unloading in VA-ECMO. Supply: demand improved with IABP but not Impella. Presented @crfheart #TCT2026 and published simultaneously @SaadEzad @divaka_perera @UKheartresearch @VPanoulas @PBSherren @K_DeSilva @DrMattRyan @hollymorgs ahajrnls.org/4icUqZy
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
Compared with aspirin, clopidogrel monotherapy associated w/ lower ischemic risk among patients with higher atherothrombotic risk, with no excess bleeding, Clopidogrel Versus Aspirin Monotherapy After PCI: from the SMART-CHOICE 3 randomized trial @hancheol
ahajrnls.org/4jKMhg7
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
#تعرف_على_الطبيب
د. عبدالله الراجحي استشاري الطب الباطني في #مكة
للوصول إلى صفحة الطبيب في #منصة_دكتوري doctorisa.com/ar/dr/cmr68f9c…
@DAbdullahSharaf
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
🫀 In cardiology fellowship, you rarely get to practise the moments that matter most. You can’t rehearse a patient in cardiogenic shock, and you don’t get to take the C arm or run the stimulator yourself until you’re already in the room.
👉 So I built Ventriculus: ventriculus.org
Free cardiology simulators that run on a working model of the heart, in your browser.
• Shock Simulator: manage a cardiogenic shock patients in the CICU, fifteen minutes at a time
• Catheterization Lab: drive the C arm and inject on real 3D anatomy, left and right catheterization
• Electrophysiology Lab: run an EP study, from baseline intervals to ablation
• Device Programmer: pacemakers, ICDs and CRT on a live rhythm
• Plus an ECG Atlas, Echo Guide and Cardiac Pharmacy
Change the heart and everything follows. Free, no ads, no account.
For education, not patient care. Feedback welcome.
#MedEd #FOAMed #CardioTwitter
How calcium score >1,000 with no significant coronary stenosis?
1️⃣ Calcium score measures plaque burden, not stenosis. A high score indicates extensive atherosclerosis but does not necessarily mean obstructive coronary disease.
2️⃣ Positive remodeling: Coronary arteries can expand outward as plaque accumulates, preserving the lumen despite substantial plaque burden.
3️⃣ Plaque distribution matters: Diffuse calcification may produce a very high calcium score without a focal, flow-limiting stenosis.
4️⃣ Calcified vs. non-calcified plaque: Dense calcium is generally associated with more stable plaque features, but it does not eliminate cardiovascular risk.
5️⃣ Statins may increase plaque calcification as part of plaque stabilization, even while reducing cardiovascular risk.
⚠️ A calcium score >1,000 indicates extensive coronary atherosclerosis and very high cardiovascular risk, even when no significant stenosis is identified.
What should we do?
• Aggressive LDL-C lowering.
• Optimum blood pressure and glycemic control.
• Address all modifiable cardiovascular risk factors.
Remember: No significant blockage does not mean no coronary artery disease. Early recognition provides an opportunity to reduce future cardiovascular events.
(MY NOTES)
Tips and Tricks About Renal Denervation (RDN)
*General principles:
-The procedure started in 2012.
-RDN in patients with higher baseline blood pressure has better results than in those with lower baseline blood pressure.
-The expected reduction in blood pressure after RDN occurs over approximately 6 months and then lasts longer.
-The initial reduction in BP during hospitalization and in the first few hours after the procedure is likely due to the effects of sedation.
The procedure is very painful, and the patient should receive deep sedation. Pain occurs during ablation.
-Body movement and heavy breathing can negatively affect the ablation results.
-The ablation (spiral) catheter should be positioned distally within the renal artery, toward the renal parenchyma, where the highest concentration of the renal nerve complex is present.
Nerves do not regenerate after ablation because the procedure targets postganglionic (demyelinated) nerve endings.
-RDN in patients with CKD and an eGFR below 40 mL/min/1.73 m² is not recommended (Class III, LOE C; ESC 2024).
-DAPT is not required for the RDN procedure unless a renal artery stent is implanted.
-A pigtail catheter can be placed at the level of the renal arteries, between T12 and L1, for aortography. The last rib is a landmark for this area.
-Normally, the left renal artery lies at a lower level than the right renal artery.
-A LIMA catheter or a JR4 catheter (shorter than a coronary guide catheter) can be used to engage the renal artery.
-The same catheter can be used on both sides.
-A coronary workhorse wire can be used to cross the renal artery; a BMW wire is one example.
-Minimize contrast use as much as possible and use the roadmap. The average contrast volume required is 50–70 mL.
-The average duration of the entire procedure is 35–60 minutes.
-Ablation can be performed in vessels with a diameter of at least 3 mm. Ablation in vessels smaller than 3 mm may lead to overheating, causing the system to stop.
-Overheating occurs when the temperature reaches 60°C.
-Every ablation is automatically programmed to last 60 seconds. An ablation duration of 45 seconds is considered sufficient.
-The catheter has a spiral design with four electrodes: electrode 1 is the most distal (near the renal parenchyma), and electrode 4 is the most proximal.
-Avoid ablation if an electrode is positioned against a bifurcation; maintain a distance of approximately 5 mm.
-For ablation of the left renal artery, use an LAO projection to separate the arterial branches from the renal border. For the right renal artery, use an RAO projection.
-The catheter has good contact with the vessel wall if the waveform is stable, with consistent waves and no significant variations.
-During ablation, impedance decreases and temperature increases. The two lines on the screen will meet in the middle.
-There is no target value for temperature or impedance. The generator’s algorithm automatically turns energy delivery on or off if the temperature is too high or if there is poor electrode contact with the vessel wall.
-More ablations have not been proven to cause more complications.
-A patient is considered a nonresponder to RDN if BP fails to decrease after 2 years.
*Patient communication: The RDN procedure should be clearly explained to the patient:
-RDN may take 6 months to have an apparent effect, and the effect may improve over time.
-RDN does not replace medical therapy but may allow a reduction in medication requirements over time.
-Like medical therapy, RDN does not replace a healthy lifestyle and diet.
-Unlike medical therapy, RDN has no proven long-term side effects.
-Unlike medical therapy, RDN provides continuous BP reduction, 24 hours a day.
-Patients with higher baseline BP generally experience greater BP reductions.
-RDN is a safe treatment option, it is not experimental, and is supported by national and international guidelines.
بفضل الله، تم إجراء أول عملية كيّ أعصاب شرايين الكلى (Renal Denervation) في مستشفى النور التخصصي، بالتعاون مع شركة Medtronic.
كل الشكر لفريق Medtronic، ولجميع أفراد الطاقم الطبي على جهودهم وتعاونهم المميز.
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
Replying to @DocSavageTJU @Jscai @mmamas1973 @mirvatalasnag @Hragy @aymanka @realarainmd @agtruesdell @sbrugaletta @SVRaoMD @SripalBangalore @SCAI
Here it is:
jscai.org/article/S2772-9303…
PDF 👇🏽
jscai.org/action/showPdf?pii…
د. عبدالله الراجحي Dr. Abdullah Alrajhi retweeted
🫀 Adenosine in transplanted hearts (TH)
• TH are DENERVATED → loss of vagal/sympathetic tone + upregulated AV-nodal adenosine receptors leads to supersensitivity (3–5x)
• So the usual 6 mg can cause profound AV block or asystole
• Start 25 μg/kg (max 1.5 mg if ≥60 kg)





















